A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)
Clinical trial NCT02082899 · COMPLETED
Trial details
- NCT number
- NCT02082899
- Sponsor
- Eleven Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-06-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.